Prediction of Childhood Epilepsy Outcome in Bangladesh

Institute of Child Health

Status: Completed

Conditions: Epilepsy

Treatments: Drug: carbamazepine; Drug: phenobarbitone

Study type: Interventional

Funder types: Other

Identifiers

NCT00381537

99NR58

Details and patient eligibility

About

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

Sex: All

Ages: 2 to 16 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Active epilepsy
• Aged 2-15 years

Exclusion criteria

• Excluded absence
• Myoclonic and malignant epilepsy syndromes
• Major motor and cognitive impairments
• Those currently receiving antiepilepsy drugs.